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Abstract:   
Background: Hyponatremia, defined by a serum sodium concentration less than 135 
mEq/L, is seen in approximately 25% of patients admitted with congestive heart failure 
(CHF). Hyponatremia on admission has been shown to increase in-hospital mortality and 
to be an independent predictor of 6month mortality. Prior work has shown that CHF 
patients with hyponatremia on admission are more likely to be Caucasian. Given its 
prognostic significance, hyponatremia and its association with patient characteristics 
warrants further study  
Methods: We queried for unique admissions to Temple University Hospital between 2011 
and 2015 with a DRG code of "291-293" to represent a heart failure admission. We 
identified admissions that had a first sodium lab value after admission available. Chi-square 
tests were performed to examine association between first Na<135 mEq/L and ethnicity, 
gender, or ethnic/gender sub-group. Statistical significance was defined as p<0.05.   
Results: 884 admissions were identified by ethnicity as either "African-American", 
"Caucasian (Non-Hispanic)" or "Hispanic". There was no association between first Na<135 
mEq/L and ethnicity (Chi-squared=2.31; p=0.31).  976 admissions were identified as either 
"male" or "female". There was no association between hyponatremia on admission and 
gender (Chi-squared=1.17; p=0.27). 768 patient admissions could be classified by both 
ethnicity and gender. The association between hyponatremia on admission and 
ethnic/gender sub-group did not achieve statistical significance (Chi-squared=9.49; 
p=0.09).   
Conclusion(s): In conclusion, our study demonstrates no statistically significant association 
between hyponatremia and the patient characteristics ethnicity and gender in a small 
sample of heart failure admissions. There was a trend toward a lower proportion of 
"African-American/Female" admissions having hyponatremia.  
Introduction: Heart failure is a complex clinical syndrome that affects more than 5.7 million 
Americans and more than 23 million people worldwide. 1 For several decades now, 
hyponatremia, defined by a serum sodium concentration less than 135 mEq/L, has been 
recognized as a not uncommon electrolyte abnormality in patients with congestive heart 
failure (CHF).2 Patients with CHF and hyponatremia have been shown to exhibit 
neurohormonal upregulation. Increases in sympathetic stimulation and activation of the 
renin angiotensin aldosterone system cause constriction of renal vasculature and sodium 
and water retention.3 Studies have shown that approximately 20-25 percent of patients 
admitted with CHF have hyponatremia at baseline.2 Hyponatremia can develop in an 
additional 15-25 percent of patients during decongestive treatment.4 Baseline 
hyponatremia at time of admission has been shown to be an independent predictor of 6-
month mortality in CHF patients.2,5-6 Baseline hyponatremia has also been associated with 
an increase in in-hospital mortality and early post-discharge mortality.5-6 What has to be 
clarified is whether there is an association between CHF patient characteristics and 
likelihood of having baseline hyponatremia. Analysis of the OPTIME-CHF registry showed 
that patients with baseline hyponatremia were more likely to be Caucasian, but without 
further investigation.6 Heart failure does not affect patients of different ethnicities in the 
same manner. African Americans, although a heterogeneous patient group, are 
disproportionately affected by heart failure and have not derived the same treatment 
benefit as Caucasian patients.7 Given the disparity in clinical impact, the purpose of this 
study is to examine the association between hyponatremia (Na<135 mEq/L) and the 
patient characteristics ethnicity and gender in a sample of acute heart failure admissions 
to further understanding of the heart failure syndrome.  
Methods: This study was approved by the Institutional Review Board at Temple University 
Hospital.  
Administrative data on all patients admitted to Temple University Hospital between August 
2011 and July 2015 was drawn from the Mckesson system maintained by TUH. This data 
was merged with clinical data from the EPIC clarity system which contained laboratory 
results on all inpatients in this timeframe.  
All patients included in analysis were greater than 18 years. We created a crosswalk of real 
identifiers with pseudo-identifiers so the analytical data set did not contain names or 
medical record numbers. The data was stored on a protected TUcloud server and uploaded 
into directly Microsoft Access for analysis. We queried for all admissions with a DRG code 
of “291-293” for a heart failure related diagnosis. We identified unique admissions using 
non-duplicate dates of admission and discharge. We then queried the admissions that had 
a first sodium lab value after admission available. We used the identifiers “ethnicity” and 
“gender” to further categorize the data for statistical analysis. Chi-Square tests were 
performed to look for association between first Na<135 mEq/L and race, gender, or 
race/gender subgroup. All statistical analyses were performed with SAS 9.4 (SAS Institute, 
Cary, NC). Statistical significance was defined as P < 0.05. There was no adjustment for 
multiple comparisons.  
Results:   
1954 unique CHF admissions were identified. Of these, 976 admissions had a first sodium 
lab value after admission available through the merged data set.  
Table 1 contains the percentage of patients of each ethnicity, gender, and ethnic/gender 
subgroup admitted with a first Na<135 mEq/L  
884 patient admissions were identified by ethnicity as either "African-American", 
"Caucasian (NonHispanic)" or "Hispanic". 123 of these admissions had baseline 
hyponatremia (first Na<135 mEq/L). There was no statistically significant association 
between baseline hyponatremia and ethnicity (p=0.315).    
976 admissions were identified as either "male" or "female". 154 of these admissions had 
baseline hyponatremia. There was no statistically significant association between baseline 
hyponatremia and gender (p=0.278).   
768 patient admissions could be classified by both ethnicity and gender. 115 patients had 
baseline hyponatremia. The association between baseline hyponatremia and 
ethnic/gender sub-group did not reach statistical significance (p=0.091).  
  
Discussion:  
This study demonstrates no statistically significant association between admission 
hyponatremia and the patient characteristics ethnicity and gender in a small sample of 
acute heart failure admissions. There was a trend in our data toward a greater proportion 
of Caucasian patient admissions having hyponatremia at baseline. This trend is in line with 
prior study of baseline hyponatremia and heart failure.6 There was also a trend toward a 
lower proportion of “African-American/Female” admissions having baseline hyponatremia 
as compared to other ethnic/gender sub-groups. Although there was no statistically 
significant association, further investigation of this trend using a larger sample size is 
needed.  
There is a clear disparity in the clinical impact of the heart failure syndrome. 
African Americans have an increased risk of developing heart failure despite adjusting for 
the higher prevalence of CHF risk factors.8 African Americans have more than twice the 
rate of hospitalization for heart failure compared to Caucasians.9 Hispanic patients have 
similarly been shown to have a higher rate of hospitalization than Caucasians. Even 
among a commercially insured population with few barriers to care, African American 
patients have been shown to have a higher incidence of heart failure and a higher rate of 
hospitalization after diagnosis.10 Further study is needed to elucidate the pathophysiology 
of heart failure in different ethnic patient populations and the dynamic interplay between 
vasopressin and heart failure.  
Hyponatremia may not simply be a prognostic indicator or marker of disease severity, but 
a contributor to the pathophysiology of the heart failure syndrome.2 Admitted CHF 
patients with baseline hyponatremia could thus represent a population with a 
pathophysiology that differs from that of normo-natremic patients. Additional research 
may be needed to determine whether vasopressin antagonists, which are known to 
normalize serum sodium levels, are associated with improved clinical outcomes in 
specific patient populations. Future work should be directed at the level of vasopressin or 
copeptin, a fragment of vasopressin precursor, in different patient populations to identify 
which patients would theoretically benefit the most from vasopressin antagonist therapy. 
Measuring vasopressin levels allows us to examine the basis of the effect of vasopressin 
antagonists as previous studies have not done so.11  
This study has several limitations. For one, it was conducted using admissions to a 
single academic medical center whose patient population is predominantly African 
American. Also, it must be stated that the African-American, Hispanic, and Caucasian 
populations each consist of a very heterogeneous patient group. Race, after all, has been 
said to be a sociopolitical construct having no scientific basis. However, there may be 
some differences in how patient populations are affected by heart failure and those 
differences should be explored in the best interest of patient care. Another limitation of 
the study is that only about half of the identified heart failure admissions did not have 
first sodium after admission available in our merged data set, thereby limiting our sample 
size. Further studies examining the association between baseline hyponatremia and 
patient characteristics should be a conducted with a larger sample of CHF patients.  
Acknowledgements: Thank You to Dr. Mark Weiner at Temple University School of 
Medicine for assisting with project design and data analysis.   
References:  
1. Chaudhry SP, Stewart GC. Advanced Heart Failure: Prevalence, Natural History, and 
Prognosis. Heart  
Failure Clinics. 2016 Jul 31;12(3):323-33. DOI: 10.1016/j.hfc.2016.03.001.  
2. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL, Fonarow GC, 
DeMarco T, Pauly DF, Rogers J, DiSalvo TG. Characterization and prognostic value of 
persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. 
Archives of Internal Medicine. 2007 Oct 8;167(18):1998-2005.  
DOI: 10.1001/archinte.167.18.1998  
3. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. New England 
Journal of  
Medicine. 1999 Aug 19;341(8):577-85. DOI: 10.1056/NEJM199908193410806  
4. Verbrugge FH, Grodin JL, Mullens W, Taylor DO, Starling RC, Tang WW. Transient 
hyponatremia during hospitalization for acute heart failure. The American journal of 
medicine. 2016 Jun 30;129(6):620-7.  
DOI:10.1016/j.amjmed.2016.01.016. Epub 2016 Feb 1  
5. Gheorghiade M, Abraham WT, Albert NM, Stough WG, Greenberg BH, O'Connor CM, 
She L, Yancy CW, Young J, Fonarow GC. Relationship between admission serum sodium 
concentration and clinical outcomes in patients hospitalized for heart failure: an 
analysis from the OPTIMIZE-HF registry. European heart journal. 2007 Apr 1;28(8):980-
8 DOI: http://dx.doi.org/10.1093/eurheartj/ehl542  
6. Klein  LO'Connor  CMLeimberger  JD  et al.  Lower serum sodium is associated with 
increased shortterm mortality in hospitalized patients with worsening heart failure: 
results from the Outcomes of a Prospective Trial of Intravenous Milrinone for 
Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005;111 (19) 
2454- 2460 DOI: 10.1161/01.CIR.0000165065.82609.3D  
7. Sharma A, Colvin-Adams M, Yancy CW. Heart failure in African Americans: Disparities 
can be overcome. Cleveland Clinic journal of medicine. 2014 May 1;81(5):301-11  
8. Okin PM, Kjeldsen SE, Dahlöf B, Devereux RB. Racial differences in incident heart failure 
during antihypertensive therapy. Circulation: Cardiovascular Quality and Outcomes. 
2011 Mar 1;4(2):157-64.  
9. Ziaeian B, Fonarow GC. National Trends in Age-Adjusted Heart Failure Hospitalizations 
From 2002 to 2013 by Gender and Ethnicity. Journal of Cardiac Failure. 2016 Aug 
1;22(8):S25.  
10. Sangaralingham LR, Shah ND, Roger VL, Dunlay SM. Racial Differences in the 
Incidence and Outcomes of Heart Failure in Commercially Insured Patients. Circulation. 
2015 Nov 10;132(Suppl 3):A14207-.  
11. Hauptman PJ, Burnett J, Gheorghiade M, Grinfeld L, Konstam MA, Kostic D, 
Krasa HB, Maggioni A, Ouyang J, Swedberg K, Zannad F. Clinical course of patients with 
hyponatremia and decompensated systolic heart failure and the effect of vasopressin 
receptor antagonism with tolvaptan. Journal of cardiac failure. 2013 Jun 30;19(6):390-
7. DOI: 10.1016/j.cardfail.2013.04.001r  
Table 1: Proportion of Patients with Hyponatremia at time of Admission ( 
 
 
Patient Characteristic        
        
Ethnicity  Total Admissions  First Na<135 
mEQ/L  
Percentage with First  
Na<135mEQ/L  
African American  637  79  12.4%  
Hispanic  147  27  15.5%  
Caucasian(Non-Hispanic)  100  17  17.0%  
    P=0.315    
        
Gender        
Male  527  77  14.6%  
Female  449  77  17.1%  
    P=0.278    
        
Ethnic/Gender Sub-group        
African American/Male  330  41  12.4%  
Hispanic/Male  99  15  15.2%  
Caucasian(Non-Hispanic)/Male  53  7  13.2%  
African American/Female  307  32  10.4%  
Hispanic/Female  47  12  25.5%  
Caucasian(Non-Hispanic)/ Female  47  8  17.1%  
    P=0.091    
